 Shaodong Dai
Concepts (391)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell | 9 | 2022 | 668 | 2.110 |
Why?
| | Nickel | 4 | 2021 | 64 | 1.660 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2022 | 1130 | 1.650 |
Why?
| | Hypersensitivity | 7 | 2021 | 253 | 1.570 |
Why?
| | Autoantigens | 7 | 2022 | 429 | 1.110 |
Why?
| | Prosthesis Failure | 2 | 2021 | 128 | 1.110 |
Why?
| | Peptides | 11 | 2022 | 999 | 1.060 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 331 | 1.030 |
Why?
| | Histocompatibility Antigens Class II | 5 | 2022 | 364 | 0.990 |
Why?
| | Models, Molecular | 26 | 2026 | 1619 | 0.920 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2022 | 3906 | 0.860 |
Why?
| | Berylliosis | 5 | 2016 | 202 | 0.860 |
Why?
| | Alzheimer Disease | 4 | 2025 | 622 | 0.790 |
Why?
| | Haptens | 2 | 2021 | 21 | 0.770 |
Why?
| | Protein Conformation | 16 | 2026 | 946 | 0.740 |
Why?
| | T-Lymphocytes | 7 | 2021 | 1984 | 0.720 |
Why?
| | Peptide Fragments | 4 | 2020 | 701 | 0.710 |
Why?
| | Transcriptome | 6 | 2022 | 1046 | 0.690 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 918 | 0.680 |
Why?
| | Insulin | 4 | 2022 | 2507 | 0.670 |
Why?
| | Joint Prosthesis | 1 | 2021 | 22 | 0.670 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2022 | 198 | 0.660 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 173 | 0.650 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 610 | 0.640 |
Why?
| | Epitopes | 3 | 2017 | 485 | 0.630 |
Why?
| | Bryostatins | 1 | 2020 | 2 | 0.630 |
Why?
| | Alternative Splicing | 1 | 2022 | 249 | 0.610 |
Why?
| | Drugs, Chinese Herbal | 2 | 2017 | 24 | 0.600 |
Why?
| | Data Mining | 2 | 2017 | 117 | 0.560 |
Why?
| | Arthroplasty, Replacement | 2 | 2020 | 47 | 0.530 |
Why?
| | Echinococcus granulosus | 1 | 2017 | 1 | 0.530 |
Why?
| | Organogold Compounds | 1 | 2017 | 5 | 0.530 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2017 | 24 | 0.520 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 67 | 0.510 |
Why?
| | Protein Processing, Post-Translational | 4 | 2018 | 477 | 0.510 |
Why?
| | Plants, Medicinal | 1 | 2016 | 23 | 0.480 |
Why?
| | Protein Binding | 16 | 2026 | 2283 | 0.470 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2021 | 175 | 0.470 |
Why?
| | Machine Learning | 1 | 2022 | 589 | 0.470 |
Why?
| | Crystallography, X-Ray | 13 | 2026 | 493 | 0.460 |
Why?
| | Anti-Bacterial Agents | 2 | 2026 | 1922 | 0.440 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2016 | 177 | 0.440 |
Why?
| | Co-Repressor Proteins | 3 | 2026 | 18 | 0.430 |
Why?
| | Drug Discovery | 1 | 2015 | 155 | 0.430 |
Why?
| | Amino Acid Sequence | 10 | 2019 | 2158 | 0.420 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 220 | 0.410 |
Why?
| | HLA-DP beta-Chains | 5 | 2016 | 87 | 0.400 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2015 | 233 | 0.390 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 32 | 0.390 |
Why?
| | Animals | 31 | 2026 | 38180 | 0.390 |
Why?
| | Mice | 22 | 2026 | 18397 | 0.370 |
Why?
| | Beryllium | 4 | 2016 | 161 | 0.370 |
Why?
| | Arthropod Proteins | 1 | 2012 | 6 | 0.360 |
Why?
| | Aprotinin | 1 | 2012 | 11 | 0.360 |
Why?
| | Salivary Proteins and Peptides | 1 | 2012 | 14 | 0.360 |
Why?
| | Ixodes | 1 | 2012 | 12 | 0.360 |
Why?
| | Ticks | 1 | 2012 | 30 | 0.350 |
Why?
| | Metals | 1 | 2013 | 142 | 0.350 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 73 | 0.350 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2022 | 20 | 0.350 |
Why?
| | Enzyme Inhibitors | 3 | 2025 | 826 | 0.320 |
Why?
| | Bacterial Proteins | 5 | 2026 | 962 | 0.320 |
Why?
| | Evolution, Molecular | 2 | 2012 | 517 | 0.310 |
Why?
| | Databases, Factual | 1 | 2016 | 1488 | 0.310 |
Why?
| | Humans | 43 | 2026 | 145307 | 0.310 |
Why?
| | Alleles | 3 | 2010 | 881 | 0.300 |
Why?
| | Binding Sites | 6 | 2017 | 1333 | 0.290 |
Why?
| | Plant Proteins | 2 | 2026 | 112 | 0.280 |
Why?
| | Salmonella | 2 | 2026 | 61 | 0.260 |
Why?
| | Ferredoxins | 1 | 2007 | 10 | 0.260 |
Why?
| | Protein Structure, Tertiary | 8 | 2012 | 862 | 0.260 |
Why?
| | Iron-Sulfur Proteins | 1 | 2007 | 47 | 0.250 |
Why?
| | Oxidoreductases | 1 | 2007 | 96 | 0.250 |
Why?
| | Medicine, Chinese Traditional | 2 | 2017 | 8 | 0.250 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2931 | 0.250 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2026 | 14 | 0.240 |
Why?
| | Mutation | 6 | 2022 | 4104 | 0.240 |
Why?
| | Peroxiredoxins | 1 | 2026 | 26 | 0.240 |
Why?
| | Zinc Fingers | 1 | 2026 | 53 | 0.230 |
Why?
| | DNA-Binding Proteins | 5 | 2026 | 1503 | 0.230 |
Why?
| | S-Adenosylmethionine | 1 | 2025 | 59 | 0.230 |
Why?
| | Salmonella Infections | 1 | 2026 | 60 | 0.220 |
Why?
| | Single-Domain Antibodies | 1 | 2025 | 15 | 0.220 |
Why?
| | Molecular Conformation | 3 | 2022 | 148 | 0.220 |
Why?
| | Antigens | 2 | 2020 | 347 | 0.220 |
Why?
| | Hybridomas | 3 | 2021 | 234 | 0.210 |
Why?
| | Histones | 4 | 2026 | 673 | 0.210 |
Why?
| | HIV Infections | 1 | 2020 | 3158 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 5 | 2019 | 2371 | 0.210 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 64 | 0.210 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2025 | 141 | 0.200 |
Why?
| | Tumor Suppressor Proteins | 1 | 2026 | 324 | 0.200 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 169 | 0.200 |
Why?
| | HLA-DR Serological Subtypes | 2 | 2013 | 4 | 0.190 |
Why?
| | Disulfides | 2 | 2022 | 96 | 0.190 |
Why?
| | Oxygenases | 1 | 2002 | 13 | 0.190 |
Why?
| | Polychlorinated Biphenyls | 1 | 2002 | 11 | 0.190 |
Why?
| | Receptors, Steroid | 1 | 2023 | 45 | 0.190 |
Why?
| | Nucleic Acids | 1 | 2024 | 72 | 0.190 |
Why?
| | Amino Acids | 2 | 2022 | 522 | 0.190 |
Why?
| | Dioxygenases | 1 | 2002 | 36 | 0.190 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 11 | 0.180 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 40 | 0.180 |
Why?
| | Hepatitis B virus | 1 | 2022 | 33 | 0.180 |
Why?
| | AlkB Enzymes | 1 | 2022 | 1 | 0.180 |
Why?
| | Hirudo medicinalis | 1 | 2022 | 1 | 0.180 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 48 | 0.180 |
Why?
| | Germ Cells | 1 | 2022 | 66 | 0.180 |
Why?
| | Leeches | 1 | 2022 | 3 | 0.180 |
Why?
| | Protein Domains | 2 | 2026 | 317 | 0.180 |
Why?
| | Rift Valley fever virus | 1 | 2021 | 3 | 0.180 |
Why?
| | Support Vector Machine | 1 | 2022 | 36 | 0.180 |
Why?
| | Biomarkers, Tumor | 2 | 2021 | 1325 | 0.180 |
Why?
| | Cell Cycle Proteins | 2 | 2026 | 630 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 2 | 2025 | 579 | 0.180 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 6 | 0.180 |
Why?
| | Transglutaminases | 1 | 2022 | 159 | 0.170 |
Why?
| | Molecular Docking Simulation | 2 | 2019 | 124 | 0.170 |
Why?
| | Protein Structure, Secondary | 3 | 2012 | 369 | 0.170 |
Why?
| | VDJ Exons | 1 | 2021 | 2 | 0.170 |
Why?
| | Structure-Activity Relationship | 2 | 2016 | 570 | 0.170 |
Why?
| | Lymphoma, Mantle-Cell | 1 | 2021 | 33 | 0.170 |
Why?
| | Early Growth Response Protein 2 | 1 | 2020 | 10 | 0.170 |
Why?
| | Glycoproteins | 2 | 2014 | 355 | 0.170 |
Why?
| | Sequence Alignment | 3 | 2012 | 368 | 0.160 |
Why?
| | GATA2 Transcription Factor | 1 | 2020 | 14 | 0.160 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 30 | 0.160 |
Why?
| | STAT5 Transcription Factor | 1 | 2020 | 52 | 0.160 |
Why?
| | HLA-DRB4 Chains | 1 | 2020 | 6 | 0.160 |
Why?
| | Environmental Pollutants | 1 | 2002 | 168 | 0.160 |
Why?
| | Muromegalovirus | 1 | 2020 | 23 | 0.160 |
Why?
| | Transcription Factor AP-1 | 1 | 2020 | 79 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 173 | 0.160 |
Why?
| | Response Elements | 1 | 2020 | 89 | 0.160 |
Why?
| | NFATC Transcription Factors | 1 | 2020 | 93 | 0.160 |
Why?
| | Polyethylene Glycols | 1 | 2025 | 655 | 0.160 |
Why?
| | Toxoplasmosis | 1 | 2020 | 43 | 0.160 |
Why?
| | Toxoplasma | 1 | 2020 | 49 | 0.160 |
Why?
| | Trace Elements | 1 | 2020 | 52 | 0.150 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 224 | 0.150 |
Why?
| | Interleukin-13 | 1 | 2020 | 144 | 0.150 |
Why?
| | Major Histocompatibility Complex | 3 | 2013 | 229 | 0.150 |
Why?
| | Cytochrome P-450 CYP3A Inducers | 1 | 2019 | 5 | 0.150 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 99 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 272 | 0.150 |
Why?
| | Virus Latency | 1 | 2020 | 90 | 0.150 |
Why?
| | Sarcoidosis | 1 | 2021 | 163 | 0.150 |
Why?
| | Mast Cells | 1 | 2020 | 146 | 0.150 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2021 | 193 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2019 | 54 | 0.150 |
Why?
| | Herpesviridae Infections | 1 | 2020 | 150 | 0.150 |
Why?
| | Hodgkin Disease | 1 | 2021 | 171 | 0.140 |
Why?
| | Purines | 1 | 2020 | 187 | 0.140 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 26 | 0.140 |
Why?
| | Protein Kinase C | 1 | 2020 | 252 | 0.140 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 192 | 0.140 |
Why?
| | Antigen Presentation | 3 | 2020 | 205 | 0.140 |
Why?
| | Chronic Disease | 3 | 2020 | 1814 | 0.140 |
Why?
| | Lysosomes | 1 | 2019 | 128 | 0.140 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2018 | 63 | 0.140 |
Why?
| | Models, Genetic | 1 | 2021 | 536 | 0.140 |
Why?
| | Thymus Gland | 1 | 2019 | 311 | 0.130 |
Why?
| | Histone Demethylases | 1 | 2018 | 38 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 824 | 0.130 |
Why?
| | Helminth Proteins | 1 | 2017 | 24 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 359 | 0.130 |
Why?
| | Glutaredoxins | 1 | 2017 | 15 | 0.130 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 59 | 0.130 |
Why?
| | Autoimmunity | 2 | 2014 | 935 | 0.130 |
Why?
| | Up-Regulation | 1 | 2020 | 853 | 0.120 |
Why?
| | Insecta | 1 | 2017 | 74 | 0.120 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2019 | 196 | 0.120 |
Why?
| | Immune Tolerance | 1 | 2019 | 379 | 0.120 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1127 | 0.120 |
Why?
| | Mice, Transgenic | 5 | 2025 | 2192 | 0.120 |
Why?
| | Kinetics | 3 | 2012 | 1630 | 0.120 |
Why?
| | Pancreas | 1 | 2019 | 342 | 0.120 |
Why?
| | Oxidation-Reduction | 3 | 2026 | 1087 | 0.120 |
Why?
| | Histocompatibility Antigens | 2 | 2025 | 102 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2022 | 768 | 0.120 |
Why?
| | Protein Folding | 1 | 2017 | 279 | 0.120 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2017 | 95 | 0.120 |
Why?
| | Pyrimidines | 1 | 2020 | 533 | 0.120 |
Why?
| | Bipolar Disorder | 1 | 2019 | 281 | 0.120 |
Why?
| | Cysteine | 1 | 2017 | 210 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 533 | 0.120 |
Why?
| | Catalytic Domain | 3 | 2021 | 234 | 0.120 |
Why?
| | Chromogranin A | 1 | 2015 | 43 | 0.110 |
Why?
| | Cancer Vaccines | 2 | 2021 | 160 | 0.110 |
Why?
| | Transcription Factors | 3 | 2017 | 1746 | 0.110 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2015 | 194 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3560 | 0.110 |
Why?
| | Conserved Sequence | 2 | 2021 | 245 | 0.110 |
Why?
| | Lamivudine | 1 | 2014 | 65 | 0.100 |
Why?
| | Azides | 1 | 2014 | 47 | 0.100 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2014 | 87 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1496 | 0.100 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1787 | 0.100 |
Why?
| | DNA | 4 | 2024 | 1467 | 0.100 |
Why?
| | HIV-1 | 1 | 2020 | 897 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2609 | 0.100 |
Why?
| | Drug Resistance, Viral | 1 | 2014 | 123 | 0.100 |
Why?
| | Signal Transduction | 4 | 2020 | 5239 | 0.100 |
Why?
| | Deoxycytidine | 1 | 2014 | 221 | 0.100 |
Why?
| | HIV | 1 | 2014 | 250 | 0.100 |
Why?
| | Computer Simulation | 2 | 2016 | 1026 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1525 | 0.090 |
Why?
| | Phosphoproteins | 1 | 2014 | 346 | 0.090 |
Why?
| | Computational Biology | 1 | 2017 | 683 | 0.090 |
Why?
| | Cross Reactions | 2 | 2011 | 130 | 0.090 |
Why?
| | Blood | 1 | 2012 | 109 | 0.090 |
Why?
| | H-2 Antigens | 1 | 2011 | 111 | 0.080 |
Why?
| | Multigene Family | 1 | 2012 | 207 | 0.080 |
Why?
| | Caenorhabditis elegans | 2 | 2025 | 337 | 0.080 |
Why?
| | Aging | 1 | 2022 | 1968 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1253 | 0.080 |
Why?
| | Ligands | 4 | 2020 | 676 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2017 | 600 | 0.080 |
Why?
| | Lysine | 1 | 2012 | 302 | 0.080 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 69 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2025 | 1173 | 0.080 |
Why?
| | RNA | 2 | 2022 | 940 | 0.080 |
Why?
| | Microbial Sensitivity Tests | 2 | 2026 | 371 | 0.080 |
Why?
| | Allergens | 1 | 2013 | 386 | 0.080 |
Why?
| | bcl-X Protein | 2 | 2006 | 45 | 0.080 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2021 | 148 | 0.070 |
Why?
| | bcl-2-Associated X Protein | 2 | 2006 | 54 | 0.070 |
Why?
| | Aged | 2 | 2022 | 26001 | 0.070 |
Why?
| | Lipids | 1 | 2014 | 712 | 0.070 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 127 | 0.070 |
Why?
| | Immunoglobulin G | 2 | 2025 | 893 | 0.070 |
Why?
| | Carrier Proteins | 2 | 2023 | 739 | 0.070 |
Why?
| | Membrane Proteins | 3 | 2006 | 1169 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 846 | 0.070 |
Why?
| | Glutamic Acid | 1 | 2010 | 251 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 116 | 0.070 |
Why?
| | Surface Plasmon Resonance | 1 | 2008 | 89 | 0.070 |
Why?
| | Stroke | 1 | 2017 | 1260 | 0.070 |
Why?
| | Synechocystis | 1 | 2007 | 3 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 17 | 0.070 |
Why?
| | Spinacia oleracea | 1 | 2007 | 10 | 0.070 |
Why?
| | Thioredoxins | 1 | 2007 | 31 | 0.060 |
Why?
| | Electron Transport | 1 | 2007 | 118 | 0.060 |
Why?
| | Burkholderia | 1 | 2006 | 13 | 0.060 |
Why?
| | Anti-HIV Agents | 1 | 2014 | 890 | 0.060 |
Why?
| | Methylation | 3 | 2018 | 242 | 0.060 |
Why?
| | Cohort Studies | 1 | 2017 | 5982 | 0.060 |
Why?
| | Hydrolases | 1 | 2006 | 55 | 0.060 |
Why?
| | NADP | 1 | 2026 | 55 | 0.060 |
Why?
| | PHD Zinc Fingers | 1 | 2026 | 14 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2012 | 692 | 0.060 |
Why?
| | Phenols | 1 | 2006 | 115 | 0.060 |
Why?
| | Female | 5 | 2021 | 78605 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2020 | 4156 | 0.060 |
Why?
| | Complementarity Determining Regions | 3 | 2011 | 53 | 0.060 |
Why?
| | Cell Line | 3 | 2020 | 2882 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4580 | 0.060 |
Why?
| | Ferric Compounds | 1 | 2025 | 55 | 0.050 |
Why?
| | Iron | 1 | 2007 | 359 | 0.050 |
Why?
| | Triazoles | 1 | 2026 | 184 | 0.050 |
Why?
| | Rats | 2 | 2026 | 5616 | 0.050 |
Why?
| | Demethylation | 1 | 2024 | 4 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2007 | 1371 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2464 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3613 | 0.050 |
Why?
| | Meiosis | 1 | 2024 | 101 | 0.050 |
Why?
| | Liposomes | 1 | 2025 | 253 | 0.050 |
Why?
| | Amyloid beta-Peptides | 1 | 2025 | 241 | 0.050 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2023 | 18 | 0.050 |
Why?
| | Lung Diseases | 1 | 2010 | 790 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1462 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 87 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2003 | 163 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2002 | 43 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 224 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 675 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 241 | 0.040 |
Why?
| | Mammals | 1 | 2024 | 293 | 0.040 |
Why?
| | Chemical Phenomena | 1 | 2021 | 81 | 0.040 |
Why?
| | Catalysis | 1 | 2002 | 322 | 0.040 |
Why?
| | Sf9 Cells | 1 | 2021 | 11 | 0.040 |
Why?
| | Antigens, Fungal | 1 | 2021 | 28 | 0.040 |
Why?
| | Spodoptera | 1 | 2021 | 40 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 2191 | 0.040 |
Why?
| | Interleukin-2 | 2 | 2015 | 437 | 0.040 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 76 | 0.040 |
Why?
| | Interferon Type I | 1 | 2022 | 145 | 0.040 |
Why?
| | Models, Chemical | 1 | 2002 | 269 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 383 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2021 | 145 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2021 | 122 | 0.040 |
Why?
| | Ubiquitin | 1 | 2021 | 86 | 0.040 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2020 | 45 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 222 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2887 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2020 | 32 | 0.040 |
Why?
| | Disease Resistance | 1 | 2020 | 29 | 0.040 |
Why?
| | Crystallization | 2 | 2015 | 146 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 2020 | 48 | 0.040 |
Why?
| | Escherichia coli Proteins | 1 | 2022 | 206 | 0.040 |
Why?
| | Antibody Affinity | 1 | 2020 | 60 | 0.040 |
Why?
| | Protozoan Proteins | 1 | 2020 | 93 | 0.040 |
Why?
| | Antibody Specificity | 1 | 2020 | 181 | 0.040 |
Why?
| | Genome | 1 | 2022 | 306 | 0.040 |
Why?
| | Carbamazepine | 1 | 2019 | 22 | 0.040 |
Why?
| | DNA Repair | 1 | 2022 | 256 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2018 | 5 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 36021 | 0.040 |
Why?
| | Viral Proteins | 1 | 2021 | 355 | 0.040 |
Why?
| | Nanoparticles | 1 | 2025 | 522 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2003 | 461 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 60 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2019 | 232 | 0.030 |
Why?
| | Genes, Bacterial | 1 | 2018 | 166 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1217 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 381 | 0.030 |
Why?
| | Apoptosis | 1 | 2006 | 2430 | 0.030 |
Why?
| | Adult | 2 | 2021 | 40627 | 0.030 |
Why?
| | Protein Denaturation | 1 | 2017 | 75 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2018 | 189 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 173 | 0.030 |
Why?
| | MafF Transcription Factor | 1 | 2017 | 1 | 0.030 |
Why?
| | Proline | 1 | 2017 | 83 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2018 | 768 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 336 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2021 | 1470 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 687 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1500 | 0.030 |
Why?
| | Risk | 1 | 2019 | 912 | 0.030 |
Why?
| | Phytotherapy | 1 | 2017 | 74 | 0.030 |
Why?
| | Arginine | 1 | 2018 | 262 | 0.030 |
Why?
| | Substrate Specificity | 2 | 2010 | 392 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 842 | 0.030 |
Why?
| | Nuclear Proteins | 2 | 2017 | 750 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2945 | 0.030 |
Why?
| | Baculoviridae | 1 | 2015 | 44 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1026 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2019 | 472 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2017 | 249 | 0.030 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2006 | 37 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 6009 | 0.030 |
Why?
| | Saliva | 1 | 2017 | 249 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2017 | 758 | 0.030 |
Why?
| | HIV Reverse Transcriptase | 1 | 2014 | 31 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2006 | 187 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 321 | 0.030 |
Why?
| | Male | 2 | 2021 | 72629 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 512 | 0.020 |
Why?
| | Sodium | 1 | 2014 | 197 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4310 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2014 | 744 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1341 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 2 | 2006 | 624 | 0.020 |
Why?
| | Lung | 2 | 2016 | 4112 | 0.020 |
Why?
| | HLA Antigens | 1 | 2013 | 232 | 0.020 |
Why?
| | Virus Replication | 1 | 2014 | 529 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2011 | 61 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 36 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 193 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 87 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 56 | 0.020 |
Why?
| | Neurons | 1 | 2019 | 1642 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 2010 | 138 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 119 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1845 | 0.020 |
Why?
| | Algorithms | 1 | 2017 | 1846 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 771 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3173 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2009 | 176 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 409 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 389 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 726 | 0.020 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2006 | 14 | 0.020 |
Why?
| | Enterotoxins | 1 | 2006 | 89 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 151 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 98 | 0.010 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 105 | 0.010 |
Why?
| | Immunotherapy | 1 | 2010 | 660 | 0.010 |
Why?
| | Point Mutation | 1 | 2006 | 243 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 940 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2506 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 12 | 0.010 |
Why?
| | B-Cell Activating Factor | 1 | 2003 | 21 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 77 | 0.010 |
Why?
| | Solubility | 1 | 2003 | 242 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 192 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2003 | 342 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 396 | 0.010 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 328 | 0.010 |
Why?
|
|
Dai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|